Company Overview of ORION Pharma GmbH
ORION Pharma GmbH develops, manufactures, and markets medicinal products in Germany. The company produces proprietary and generic medicines for humans and animal health, as well as active pharmaceutical ingredients. The company conducts pharmaceutical research operations, mainly in the first phases of the research process, the preclinical research aiming at creating new drug molecules for the subsequent clinical trials in patients. The company conducts research in the two therapeutic areas, including Central Nervous System (CNS) and Oncology & Critical Care (OCC). The company was founded in 1917 and is based in Hamburg, Germany. ORION Pharma GmbH operates as a subsidiary of Orion Oyj.
Founded in 1917
49 40 899 6890
49 40 899 68996
Key Executives for ORION Pharma GmbH
Similar Private Companies By Industry
|3B Pharmaceuticals GmbH||Europe|
|Accelsiors Group International||Europe|
|Aenova Group GmbH||Europe|
|Aenova Holding GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ORION Pharma GmbH, please visit www.orionpharma.de. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.